AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr | ₹2,844 Cr | ₹2,365 Cr |
What is the latest Profit After Tax of AUROBINDO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,928 Cr |
Mar2023 | ₹2,647 Cr |
Mar2022 | ₹5,334 Cr |
Mar2021 | ₹2,844 Cr |
Mar2020 | ₹2,365 Cr |
How is Profit After Tax of AUROBINDO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,928 Cr | -27.18 | |
Mar2023 | ₹2,647 Cr | -50.37 | |
Mar2022 | ₹5,334 Cr | 87.57 | |
Mar2021 | ₹2,844 Cr | 20.27 | |
Mar2020 | ₹2,365 Cr | - |
Compare Profit After Tax of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,359.5 Cr | -5.8% | -8.4% | -24.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -5.8% |
-8.4% |
-24.6% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses